secwatch / observer
8-K filed January 8, 2025, 6:59 PM ET ticker VOR CIK 0001817229
leadership confidence high sentiment neutral materiality 0.60

Vor Bio appoints Erez Kalir to board, filling new seat linked to Reid Hoffman-led PIPE

Vor Biopharma Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Erez Kalir

Director
VOR · Vor Biopharma Inc.
Effective
2025-01-06
Filed
January 8, 2025, 6:59 PM ET
On January 6, 2025 the Board of Directors (the “Board”) of Vor Biopharma Inc. (the “Company”) increased the size of the Board from seven to eight members and appointed Erez Kalir to fill the resulting vacancy, to serve on the Board as an independent Class III director until the Company’s 2027 annual meeting of stockholders and until his successor is duly elected and qualified.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Erez Kalir was appointed as Director at Vor Biopharma Inc..

Action
appointed
Role
Director
Exact text from the filing
On January 6, 2025 the Board of Directors (the “Board”) of Vor Biopharma Inc. (the “Company”) increased the size of the Board from seven to eight members and appointed Erez Kalir to fill the resulting vacancy, to serve on the Board as an independent Class III director until the Company’s 2027 annual meeting of stockholders and until his successor is duly elected and qualified.
View on SEC.gov

Vor Biopharma Inc. filing history →

Source: SEC EDGAR
accession 0001193125-25-003259
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.